Onyx Pharmaceuticals to Present at Upcoming Conferences
Richmond, California — Apr. 19, 2004
Contact:
Julie Wood
510-262-8757
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at three investment conferences in April and May.
The Second Annual White Mountain Capital Biotechnology Conference:
The first presentation will be at The Second Annual White Mountain Capital Biotechnology Conference in New York City, New York, on Thursday, April 22, at 10:10 a.m. Eastern Time.
Morgan Stanley Global Healthcare Unplugged Conference:
Subsequently, Onyx will present at the Morgan Stanley Global Healthcare Unplugged Conference in Miami, Florida, on Wednesday, May 5 at 11:15 a.m. Eastern Time. Interested parties may access a live webcast of the presentation at:
http://customer.talkpoint.com/MORG007/050504a_cf/default.asp?entity=onyx
SunTrust Robinson Humphrey Therapeutics Conference:
Finally, Onyx will present at the SunTrust Robinson Humphrey Therapeutics Conference in New York City, New York on Tuesday, May 11 at 9:30 a.m. Eastern Time. Interested parties may access a live webcast of the presentation at:
https://www.suntrustrh.com/ConferencesEvents/conferencedetails.asp?cid=10
It is recommended that viewers log on 15 minutes early in order to register and download any necessary software. If you are unable to participate during either of the live webcasts, a recorded replay of the presentations will be available within 24 hours of the completion of the presentations. The replays will generally remain available for one month following the presentation dates.
Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its partners, the company is developing small molecule drugs, including BAY 43 9006 with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's web site at www.onyx pharm.com.
Back to 2004 Press Releases
